Geode Capital Management, LLC Soleno Therapeutics Inc Transaction History

Geode Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.14 - $0.23 $8,139 - $13,372	58,140 Added 13.51%	488,393 $90,000
Q3 2021 Nov 12, 2021	BUY	$0.8 - $1.12 $14,548 - $20,367	18,185 Added 4.41%	430,253 $397,000
Q2 2021 Aug 13, 2021	SELL	$0.97 - $1.32 $403,207 - $548,694	-415,678 Reduced 50.22%	412,068 $469,000
Q1 2021 May 12, 2021	BUY	$1.24 - $3.3 $134,210 - $357,172	108,234 Added 15.04%	827,746 $1.04 Million
Q4 2020 Feb 12, 2021	BUY	$1.61 - $2.23 $245,531 - $340,083	152,504 Added 26.9%	719,512 $1.39 Million
Q3 2020 Nov 13, 2020	BUY	$1.71 - $2.51 $340,515 - $499,821	199,132 Added 54.13%	567,008 $1.42 Million
Q2 2020 Aug 13, 2020	BUY	$1.77 - $4.23 $403,048 - $963,217	227,711 Added 162.46%	367,876 $816,000
Q1 2020 May 14, 2020	BUY	$1.64 - $3.85 $136,556 - $320,574	83,266 Added 146.34%	140,165 $333,000
Q4 2019 Feb 13, 2020	BUY	$1.35 - $2.95 $29,432 - $64,315	21,802 Added 62.12%	56,899 $167,000
Q2 2019 Aug 14, 2019	BUY	$1.93 - $2.95 $11,699 - $17,882	6,062 Added 20.88%	35,097 $98,000
Q3 2018 Nov 13, 2018	BUY	$1.95 - $3.07 $56,618 - $89,137	29,035 New	29,035 $62,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $441M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.